SC 13G/A

AMENDMENT NO.15 TO SCHEDULE 13G

Company: Corbus Pharmaceuticals Holdings, Inc.
Filed: May 11, 2021
Accession Number: 0001213900-21-025576

View Document ↗ View on SEC.gov ↗